Physician profile
Cybele Fishman
NPI 1033181748
$2,913.24
in general payments reported to CMS, 2019-2025
17 companies · $17.44 in 2025
The $17.44 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.77 · 2020: $84.15 · 2021: $244 · 2022: $743 · 2023: $1,678 · 2024: $65.80 · 2025: $17.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,586 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,586.41 |
| Education | $174.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $998.68 | 2019-2023 | Tremfya |
| Abbvie INC. | $370.36 | 2021-2025 | |
| Genzyme Corporation | $255.85 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $209.77 | 2022-2023 | |
| Incyte Corporation | $208.85 | 2022-2023 | Opzelura |
| Galderma Laboratories, L.P. | $155.61 | 2021-2023 | |
| Allergan, INC. | $114.65 | 2019-2021 | |
| Arcutis Biotherapeutics, INC. | $113.73 | 2023-2024 | Zoryve |
| Amgen INC. | $86.40 | 2021-2023 | Otezla |
| Dermavant Sciences, INC. | $79.55 | 2023-2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $78.79 | 2022-2023 | Dupixent |
| Almirall LLC | $65.67 | 2021-2022 | |
| Leo Pharma INC. | $54.88 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $41.87 | 2021-2023 | Winlevi, Absorica Ld |
| Pfizer INC. | $41.74 | 2020-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.04 | 2021 | |
| Lilly USA, LLC | $14.80 | 2023 | Taltz, Olumiant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cybele Fishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.